Background: The association between body mass index (BMI) and long-term outcomes of patients with ICC has not been well defined. We sought to define the presentation and oncologic outcomes of patients with ICC undergoing curative-intent resection, according to their BMI category. Methods: Patients who underwent resection of ICC were identified in a multi-institutional database. Patients were categorized as normal weight (BMI 18.5e24.9 kg/m2 ), overweight (BMI 25.0e29.9 kg/m2 ) and obese (BMI30 kg/m2 ) according to the World Health Organization (WHO) definition. Impact of clinico-pathological factors on recurrence-free survival (RFS) was assessed using Cox proportional hazards model among patients in the three BMI categories. Results: Among a total of 790 patients undergoing curative-intent resection of ICC in the analytic cohort, 399 (50.5%) had normal weight, 274 (34.7%) were overweight and 117 (14.8%) were obese. Caucasian patients were more likely to be obese (66.7%, n ¼ 78) and overweight (47.1%, n ¼ 129) compared with Asian (obese: 18.8%, n ¼ 22; overweight: 46%, n ¼ 126) and other races (obese: 14.5%, n ¼ 17; overweight: 6.9%, n ¼ 19)(p < 0.001). There were no differences in the presence of cirrhosis (10.9%, vs. 12.8%, vs. 12.9%), preoperative jaundice (8.6% vs. 9.5% vs. 12.0%), or levels of CA 19e9 (75, IQR 24.6e280 vs. 50.9, IQR 17.9 e232 vs. 43, IQR 16.9e192.7) among the BMI groups (all p > 0.05). On multivariable analysis, increased BMI was an independent risk factor for tumor recurrence (OR 1.16, 95% CI 1.02e1.32, for every 5 unit increase).

Additional Metadata
Keywords Intrahepatic cholangiocarcinoma, Recurrence, BMI, Obesity, Prognosis
Persistent URL dx.doi.org/10.1016/j.ejso.2019.03.004, hdl.handle.net/1765/117857
Journal European Journal of Surgical Oncology
Citation
Merath, K., Mehta, R., Hyer, J.M., Bagante, F, Sahara, K., Alexandrescu, S., … Pawlik, TM. (2019). Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis. European Journal of Surgical Oncology, 45(6), 1084–1091. doi:10.1016/j.ejso.2019.03.004